When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic

被引:7
|
作者
Nebbioso, Andrea [1 ]
Ogundipe, Oluwakemi F. [1 ]
Repetto, Ernestina Carla [1 ]
Mekiedje, Calorine [1 ]
Sanke-Waigana, Hugues [2 ]
Ngaya, Gilles [2 ]
Ingelbeen, Brecht [3 ]
Gil-Cuesta, Julita [1 ]
机构
[1] Med Sans Frontieres Operat Ctr Brussels MSF OCB, Rue Arbre Benit 46, B-1050 Brussels, Belgium
[2] Inst Pasteur, Bangui, Cent Afr Republ
[3] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium
关键词
Antibiotic resistance; Neonatal sepsis; Neonatal infection; Neonatal intensive care unit; Blood culture; Klebsiella; Escherichia coli; Gram-negative bacteria; Central-African Republic; Sub-Saharan Africa; ANTIMICROBIAL RESISTANCE; DATA-COLLECTION; CASE-DEFINITION; PRETERM BIRTH; SEPSIS; PATHOGENS; MORTALITY; BURDEN; CHALLENGES; GUIDELINES;
D O I
10.1186/s12887-021-02911-w
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Infectious diseases account for the third most common cause of neonatal deaths. Globally, antibiotic resistance (ABR) has been increasingly challenging neonatal sepsis treatment, with 26 to 84% of gram-negative bacteria resistant to third-generation cephalosporins. In sub-Saharan Africa, limited evidence is available regarding the neonatal microbiology and ABR. To our knowledge, no studies have assessed neonatal bacterial infections and ABR in Central-African Republic (CAR). Therefore, this study aimed to describe the pathogens isolated and their specific ABR among patients with suspected antibiotic-resistant neonatal infection admitted in a CAR neonatal unit. Methods This retrospective cohort study included neonates admitted in the neonatal unit in Bangui, CAR, from December 2018 to March 2020, with suspected antibiotic-resistant neonatal infection and subsequent blood culture. We described the frequency of pathogens isolated from blood cultures, their ABR prevalence, and factors associated with fatal outcome. Results Blood cultures were positive in 33 (26.6%) of 124 patients tested (17.9% for early-onset and 46.3% for late-onset infection; p = 0.002). Gram-negative bacteria were isolated in 87.9% of positive samples; with most frequently isolated bacteria being Klebsiella pneumoniae (39.4%), Escherichia coli (21.2%) and Klebsiella oxytoca (18.2%). All tested bacteria were resistant to ampicillin. Resistance to third-generation cephalosporins was observed in 100% of tested Klebsiella pneumoniae, 83.3% of isolated Klebsiella oxytoca and 50.0% of tested Escherichia coli. None of the tested bacteria were resistant to carbapenems. Approximately 85.7 and 77.8% of gram-negative tested bacteria were resistant to first-line (ampicillin-gentamicin) and second-line (third-generation cephalosporins) treatments, respectively. In hospital mortality, adjusted for blood culture result, presence of asphyxia, birth weight and sex was higher among neonates with positive blood culture (adjusted relative risk [aRR] = 2.32; 95% confidence interval [CI] = 1.17-4.60), male sex (aRR = 2.07; 95% CI = 1.01-4.26), asphyxia (aRR = 2.42; 95% CI = 1.07-5.47) and very low birth weight (1000-1499 g) (aRR = 2.74; 95% CI = 1.3-5.79). Conclusion Overall, 77.8% of confirmed gram-negative neonatal infections could no longer effectively be treated without broad-spectrum antibiotics that are not routinely used in sub-Saharan Africa referral hospitals. Carbapenems should be considered an option in hospitals with surveillance and antibiotic stewardship.
引用
收藏
页数:11
相关论文
共 8 条
  • [1] When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic
    Andrea Nebbioso
    Oluwakemi F. Ogundipe
    Ernestina Carla Repetto
    Calorine Mekiedje
    Hugues Sanke-Waigana
    Gilles Ngaya
    Brecht Ingelbeen
    Julita Gil-Cuesta
    [J]. BMC Pediatrics, 21
  • [2] Virological Response and Resistance Profiles After 24 Months of First-Line Antiretroviral Treatment in Adults Living in Bangui, Central African Republic
    Pere, Helene
    Charpentier, Charlotte
    Mbelesso, Pascal
    Dandy, Marius
    Matta, Mathieu
    Moussa, Sandrine
    Longo, Jean De Dieu
    Gresenguet, Gerard
    Abraham, Bruno
    Belec, Laurent
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (04) : 315 - 323
  • [3] Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate
    Yoon, Hyuk
    Kim, Nayoung
    Lee, Byoung Hwan
    Hwang, Tae Jun
    Lee, Dong Ho
    Park, Young Soo
    Nam, Ryoung Hee
    Jung, Hyun Chae
    Song, In Sung
    [J]. HELICOBACTER, 2009, 14 (05) : 77 - 85
  • [4] Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
    Lee, Byoung Hwan
    Kim, Nayoung
    Hwang, Tae Jun
    Lee, Sang Hyub
    Park, Young Soo
    Hwang, Jin-Hyeok
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Lee, Dong Hoo
    Jung, Hyun Chae
    Song, In Sung
    [J]. HELICOBACTER, 2010, 15 (01) : 38 - 45
  • [5] Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies
    Hamers, Raph L.
    Sigaloff, Kim C. E.
    Wensing, Annemarie M.
    Wallis, Carole L.
    Kityo, Cissy
    Siwale, Margaret
    Mandaliya, Kishor
    Ive, Prudence
    Botes, Mariette E.
    Wellington, Maureen
    Osibogun, Akin
    Stevens, Wendy S.
    de Wit, Tobias F. Rinke
    Schuurman, Rob
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (11) : 1660 - 1669
  • [6] Virological Response and Resistance Profiles After 18 to 30 Months of First- or Second-/Third-Line Antiretroviral Treatment: A Cross-Sectional Evaluation in HIV Type 1-Infected Children Living in the Central African Republic
    Charpentier, Charlotte
    Gody, Jean-Chrysostome
    Mbitikon, Olivia
    Moussa, Sandrine
    Matta, Mathieu
    Pere, Helene
    Fournier, Julien
    Longo, Jean De Dieu
    Belec, Laurent
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (01) : 87 - 94
  • [7] HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon
    Mihimit, Abdoulaye
    Adawaye, Chatte
    Pere, Helene
    Costiniuk, Cecilia
    Koyalta, Donato
    Mbopi-Keou, Francois-Xavier
    Bouassa, Ralph-Sydney Mboumba
    Talla, Frederic
    Moussa, Sandrine
    Longo, Jean De Dieu
    Tchombou, Bertin Hig-Zounet
    Gresenguet, Gerard
    Charpentier, Charlotte
    Belec, Laurent
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2020, 5 (03)
  • [8] Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
    Xie, Yong
    Zhu, Zhenhua
    Wang, Jiangbin
    Zhang, Lingxia
    Zhang, Zhenyu
    Lu, Hong
    Zeng, Zhirong
    Chen, Shiyao
    Liu, Dongsheng
    Lv, Nonghua
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)